Characterization of the expanded T cell population in infectious mononucleosis: Apoptosis, expression of apoptosis-related genes, and Epstein- Barr virus (EBV) status

Clinical and Experimental Immunology

Volumn 120, Issue 2, 2000, Pages 294-300

  Verbeke, Caroline S ^a,c   Wenthe, U ^a   Bergler, W F ^b   Zentgraf, H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Epstein Barr virus; Infectious mononucleosis; T cells apoptosis

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; FAS ANTIGEN; FAS LIGAND; KI 67 ANTIGEN; LIGAND; PROTEIN BAX; PROTEIN BCL 2; VIRUS RNA;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFECTIOUS MONONUCLEOSIS; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; RNA ANALYSIS; T LYMPHOCYTE SUBPOPULATION; TONSILLECTOMY; VIRUS DETECTION; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, CD3; ANTIGENS, CD45; ANTIGENS, CD79; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CHILD; CHILD, PRESCHOOL; FAS LIGAND PROTEIN; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFECTIOUS MONONUCLEOSIS; KI-67 ANTIGEN; MALE; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANTIGEN, B-CELL; T-LYMPHOCYTES;

EID: 0034030476     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01181.x     Document Type: Article

References (39)

1. 1 Liebowitz D, Kieff E. Epstein-Barr virus. In: Roizman B, Whitley RJ, Lopez C, eds. The human herpesviruses. New York: Raven Press, 1993:107-72.
2. 2 Gratama JW, Oosterveer MAP, Zwaan FE, Lepoutre J, Klein G, Ernberg I. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci USA 1988; 85:8693-6.
3. 3 Niedobitek G, Hamilton-Dutoit S, Herbst H, Finn T, Vetner M, Pallesen G, Stein H. Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization. Hum Pathol 1989; 20:796-9.
4. 4 Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells. J Pathol 1997; 182:151-9.
5. 5 Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 1995; 85:744-50.
6. 6 Jones JF, Shurin S, Abramowsky C et al. T-cell lymphoma containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. N Engl J Med 1988; 318:733-41.
7. 7 Kawaguchi H, Miyashita T, Herbst H et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 1993; 92:1444-50.
8. 8 Pallesen G, Hamilton-Dutoit SJ, Zhou X. The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field. Adv Cancer Res 1994; 62:179-239.
9. 9 Kelleher CA, Dreyfus DH, Jones JF, Gelfand EW. EBV infection of T cells: potential role in malignant transformation. Sem Canc Biol 1996; 7:197-207.
10. 10 Fisher MMS, Guerra CG, Hickman JR, Hensley RE, Doe RH, Dunn CD, Hall RB. Peripheral Blood lymphocyte apoptosis. A clue to the diagnosis of acute infectious mononucleosis. Arch Pathol Lab Med 1996; 120:951-5.
11. 11 Matsuoka M, Hamada K, Saika T, Mizobuti N, Takahashi I. Apoptosis in infectious mononucleosis. Rinsho-Ketsueki 1997; 38:727-33.
12. 12 Tamaru Y, Miyawaki T, Iwai K, Tsuji T, Nibu R, Yachie A, Koizumi S, Taniguchi N. Absence of bcl-2 expression by activated CD45RO+ T lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death. Blood 1993; 82:521-7.
13. 13 Leithäuser F, Dhein J, Mechtersheimer G et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993; 69:415-29.
14. 14 Verbeke CS, Wenthe U, Zentgraf H. Fas ligand expression in the germinal centre. J Pathol 1999; 189:155-60.
15. 15 Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 1995; 14:1129-35.
16. 16 Bai MC, Jiwa NM, Horstman A et al. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease. J Pathol 1994; 174:49-55.
17. 17 Garnier J-L, Cooper NR, Cannon MJ. Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice. Am J Pathol 1993; 142:353-8.
18. 18 Baumgarten E, Herbst H, Schmitt M, Seeger KH, Schulte-Overberg U, Henze G. Life-threatening infectious mononucleosis: is it correlated with virus-induced T cell proliferation? Clin Infect Dis 1994; 19:152-6.
19. 19 Tokunaga M, Uemura Y, Tokudome T, Sato E. Epstein-Barr virus-infected T cells in infectious mononucleosis. Acta Pathol Japon 1993; 43:146-7.
20. 20 Anagnostopoulos I, Hummel M, Stein H. Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review. Leuk Lymph 1995; 19:1-12.
21. 21 Zhou XG, Hamilton-Dutoit S, Yan QH, Pallesen G. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology 1994; 24:115-22.
22. 22 Ho JWY, Ho FCS, Chan ACL, Liang RHS, Srivastava G. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas. J Pathol 1998; 185:79-85.
23. 23 Hojo I, Takanashi M, Hirai K, Mori S. Increased number of Epstein-Barr virus latently infected B-cells in T-cell non-Hodgkin's lymphoma tissues. Arch Virol 1995; 140:1419-26.
24. 24 Uehara T, Miyawaki T, Ohta K, Tamaru Y, Yokoi T, Nakamura S, Taniguchi N. Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood 1992; 80:452-8.
25. 25 Russell JH, White CL, Loh DY, Meleedy-Rey P. Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci USA 1991; 88:2151-5.
26. 26 Akbar AN, Borthwick N, Salmon M et al. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 1993; 178:428-38.
27. 27 Borthwick NJ, Bofill M, Hassan I, Panayiotidis P, Janossy G, Salmon M, Akbar AN. Factors that influence activated CD8 (+) T cell apoptosis in patients with acute herpesvirus infections: loss of costimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-x expression. Immunology 1996; 88:508-15.
28. 28 Akbar AN, Borthwick NJ, Wickremasinghe RG et al. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 1996; 26:294-9.
29. 29 Vella AT, Dow S, Potter TA, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci USA 1998; 95:3810-5.
30. 30 Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Exp Med 1999; 189:521-30.
31. 31 Pilling D, Akbar AN, Girdlestone J et al. Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol 1999; 29:1041-50.
32. 32 Schmidt C, Burman K, Moss DJ, Ryan J, Burrows SR, Misko IS. Interleukin-2 receptors in infectious mononucleosis. Immunol Letters 1989; 23:139-42.
33. 33 Ebihara T, Sakai N, Koyama S. CD8+ T cell subsets of cytotoxic T lymphocytes induced by Epstein-Barr virus infection in infectious mononucleosis. Tohoku J Exp Med 1990; 162:213-24.
34. 34 Razvi ES, Jiang Z, Woda BA, Welsh RM. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and bcl-2 transgenic mice. Am J Pathol 1995; 157:79-91.
35. 35 Ito M, Watanabe M, Ihara T, Kamiya H, Sakura M. Fas antigen and bcl 2 expression on lymphocytes cultured with cytomegalovirus and varicella zoster virus antigen. Cell Immunol 1995; 160:173-7.
36. 36 Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH. Autocrine T cell suicide mediated by APO-1 (Fas/CD95). Nature 1995; 373:438-41.
37. 37 Ju S-T, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373:444-8.
38. 38 Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996; 272:1947-50.
39. 39 Scheel-Toellner D, Pilling D, Akbar AN, Hardie D, Lombardi G, Salmon M, Lord JM. Inhibition of T cell apoptosis by IFN-beta rapidly reverses nuclear translocation of protein kinase C-delta. Eur J Immunol 1999; 29:2603-12.